Notably, temozolomide is not a potent direct cytotoxic agent [39], and the role of survivin in mediating therapeutic resistance to other agents in glioblastoma, especially those that mediate potent apoptosis such as paclitaxel [40], panobinostat [41], and marizomib [42], is unknown. The gene discussed is BIRC5; the disease is glioblastoma.